A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists
ACS Nano · 05.03.2024 · 18 (9) · 6845-6862
DOI: 10.1021/acsnano.3c04471 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 22.02.2024. Verfasst von Jessalyn J Baljon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 128-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIDCR NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.
- Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, Tennessee 37235, United States.
- Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
- Northwestern University Atomic and Nanoscale Characterization Experimental (NUANCE) Center, Northwestern University, Evanston, Illinois 60208, United States.
- Vanderbilt Institute of Chemical Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States.
- Department of Veteran Affairs Tennessee Valley Healthcare System, Nashville, Tennessee 37212, United States.
ORCID-Profile: Hayden M Pagendarm, Kyle W Becker, John T Wilson
Förderung
- BLRD VA
- NIDCR NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- Vanderbilt-Ingram Cancer Center
- National Cancer Institute
Zitieren
APA
Baljon, J. J., Kwiatkowski, A. J., Pagendarm, H. M., Stone, P. T., Kumar, A., Bharti, V., Schulman, J. A., Becker, K. W., Roth, E. W., Christov, P. P., Joyce, S., & Wilson, J. T. (2024). A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists. ACS Nano, 18(9), 6845-6862. https://doi.org/10.1021/acsnano.3c04471
Vancouver
Baljon JJ, Kwiatkowski AJ, Pagendarm HM, Stone PT, Kumar A, Bharti V, et al. A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists. ACS Nano. 2024;18(9):6845-6862. doi:10.1021/acsnano.3c04471
BibTeX
@article{Baljon2024,
author = {Baljon, Jessalyn J and Kwiatkowski, Alexander J and Pagendarm, Hayden M and Stone, Payton T and Kumar, Amrendra and Bharti, Vijaya and Schulman, Jacob A and Becker, Kyle W and Roth, Eric W and Christov, Plamen P and Joyce, Sebastian and Wilson, John T},
title = {A Cancer Nanovaccine for Co-Delivery of Peptide Neoantigens and Optimized Combinations of STING and TLR4 Agonists},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {9},
pages = {6845--6862},
doi = {10.1021/acsnano.3c04471}
}
EUVIMED